Drug Manufacturers - Specialty & Generic
Compare Stocks
2 / 10Stock Comparison
PRGO vs HLN
Revenue, margins, valuation, and 5-year total return — side by side.
Drug Manufacturers - Specialty & Generic
PRGO vs HLN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
| Market Cap | $1.60B | $40.84B |
| Revenue (TTM) | $4.25B | $22.01B |
| Net Income (TTM) | $-1.43B | $3.18B |
| Gross Margin | 35.1% | 63.9% |
| Operating Margin | -26.4% | 21.4% |
| Forward P/E | 5.5x | 21.9x |
| Total Debt | $37M | $8.59B |
| Cash & Equiv. | $532M | $1.32B |
PRGO vs HLN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jul 22 | May 26 | Return |
|---|---|---|---|
| Perrigo Company plc (PRGO) | 100 | 27.8 | -72.2% |
| Haleon plc (HLN) | 100 | 130.4 | +30.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PRGO vs HLN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PRGO is the clearest fit if your priority is income & stability and growth exposure.
- Dividend streak 10 yrs, beta 1.18, yield 9.9%
- Rev growth -2.8%, EPS growth -7.2%, 3Y rev CAGR -1.5%
- Lower volatility, beta 1.18, Low D/E 1.2%, current ratio 2.76x
HLN carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 29.8% 10Y total return vs PRGO's -78.5%
- 14.5% margin vs PRGO's -33.5%
- Beta 0.06 vs PRGO's 1.18
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -2.8% revenue growth vs HLN's -4.0% | |
| Value | Lower P/E (5.5x vs 21.9x) | |
| Quality / Margins | 14.5% margin vs PRGO's -33.5% | |
| Stability / Safety | Beta 0.06 vs PRGO's 1.18 | |
| Dividends | 9.9% yield, 10-year raise streak, vs HLN's 2.0% | |
| Momentum (1Y) | -11.9% vs PRGO's -49.3% | |
| Efficiency (ROA) | 10.0% ROA vs PRGO's -16.7%, ROIC 7.6% vs -17.1% |
PRGO vs HLN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
PRGO vs HLN — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
HLN leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
HLN is the larger business by revenue, generating $22.0B annually — 5.2x PRGO's $4.3B. HLN is the more profitable business, keeping 14.5% of every revenue dollar as net income compared to PRGO's -33.5%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $4.3B | $22.0B |
| EBITDAEarnings before interest/tax | -$1.1B | $5.3B |
| Net IncomeAfter-tax profit | -$1.4B | $3.2B |
| Free Cash FlowCash after capex | $145M | $3.1B |
| Gross MarginGross profit ÷ Revenue | +35.1% | +63.9% |
| Operating MarginEBIT ÷ Revenue | -26.4% | +21.4% |
| Net MarginNet income ÷ Revenue | -33.5% | +14.5% |
| FCF MarginFCF ÷ Revenue | +3.4% | +14.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | -2.5% | -0.4% |
| EPS Growth (YoY)Latest quarter vs prior year | -31.0% | +18.8% |
Valuation Metrics
PRGO leads this category, winning 5 of 5 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $1.6B | $40.8B |
| Enterprise ValueMkt cap + debt − cash | $1.1B | $50.7B |
| Trailing P/EPrice ÷ TTM EPS | -1.13x | 18.83x |
| Forward P/EPrice ÷ next-FY EPS est. | 5.52x | 21.89x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.23x |
| EV / EBITDAEnterprise value multiple | — | 13.51x |
| Price / SalesMarket cap ÷ Revenue | 0.38x | 2.80x |
| Price / BookPrice ÷ Book value/share | 0.55x | 1.86x |
| Price / FCFMarket cap ÷ FCF | 11.04x | 15.32x |
Profitability & Efficiency
HLN leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
HLN delivers a 19.9% return on equity — every $100 of shareholder capital generates $20 in annual profit, vs $-49 for PRGO. PRGO carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to HLN's 0.52x. On the Piotroski fundamental quality scale (0–9), HLN scores 8/9 vs PRGO's 5/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -48.6% | +19.9% |
| ROA (TTM)Return on assets | -16.7% | +10.0% |
| ROICReturn on invested capital | -17.1% | +7.6% |
| ROCEReturn on capital employed | -13.9% | +8.6% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 8 |
| Debt / EquityFinancial leverage | 0.01x | 0.52x |
| Net DebtTotal debt minus cash | -$495M | $7.3B |
| Cash & Equiv.Liquid assets | $532M | $1.3B |
| Total DebtShort + long-term debt | $37M | $8.6B |
| Interest CoverageEBIT ÷ Interest expense | -6.91x | 7.80x |
Total Returns (Dividends Reinvested)
HLN leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HLN five years ago would be worth $12,985 today (with dividends reinvested), compared to $4,057 for PRGO. Over the past 12 months, HLN leads with a -11.9% total return vs PRGO's -49.3%. The 3-year compound annual growth rate (CAGR) favors HLN at 3.3% vs PRGO's -25.1% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -14.1% | -7.0% |
| 1-Year ReturnPast 12 months | -49.3% | -11.9% |
| 3-Year ReturnCumulative with dividends | -58.0% | +10.1% |
| 5-Year ReturnCumulative with dividends | -59.4% | +29.8% |
| 10-Year ReturnCumulative with dividends | -78.5% | +29.8% |
| CAGR (3Y)Annualised 3-year return | -25.1% | +3.3% |
Risk & Volatility
HLN leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
HLN is the less volatile stock with a 0.06 beta — it tends to amplify market swings less than PRGO's 1.18 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HLN currently trades 80.3% from its 52-week high vs PRGO's 40.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.18x | 0.06x |
| 52-Week HighHighest price in past year | $28.44 | $11.42 |
| 52-Week LowLowest price in past year | $9.23 | $8.71 |
| % of 52W HighCurrent price vs 52-week peak | +40.9% | +80.3% |
| RSI (14)Momentum oscillator 0–100 | 50.2 | 34.8 |
| Avg Volume (50D)Average daily shares traded | 3.3M | 8.0M |
Analyst Outlook
PRGO leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates PRGO as "Hold" and HLN as "Buy". Consensus price targets imply 71.8% upside for PRGO (target: $20) vs 11.2% for HLN (target: $10). For income investors, PRGO offers the higher dividend yield at 9.88% vs HLN's 1.96%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $20.00 | $10.20 |
| # AnalystsCovering analysts | 36 | 4 |
| Dividend YieldAnnual dividend ÷ price | +9.9% | +2.0% |
| Dividend StreakConsecutive years of raises | 10 | 2 |
| Dividend / ShareAnnual DPS | $1.15 | $0.13 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.1% |
HLN leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). PRGO leads in 2 (Valuation Metrics, Analyst Outlook).
PRGO vs HLN: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is PRGO or HLN a better buy right now?
For growth investors, Perrigo Company plc (PRGO) is the stronger pick with -2.
8% revenue growth year-over-year, versus -4. 0% for Haleon plc (HLN). Haleon plc (HLN) offers the better valuation at 18. 8x trailing P/E (21. 9x forward), making it the more compelling value choice. Analysts rate Haleon plc (HLN) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PRGO or HLN?
On forward P/E, Perrigo Company plc is actually cheaper at 5.
5x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — PRGO or HLN?
Over the past 5 years, Haleon plc (HLN) delivered a total return of +29.
8%, compared to -59. 4% for Perrigo Company plc (PRGO). Over 10 years, the gap is even starker: HLN returned +29. 8% versus PRGO's -78. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PRGO or HLN?
By beta (market sensitivity over 5 years), Haleon plc (HLN) is the lower-risk stock at 0.
06β versus Perrigo Company plc's 1. 18β — meaning PRGO is approximately 1833% more volatile than HLN relative to the S&P 500. On balance sheet safety, Perrigo Company plc (PRGO) carries a lower debt/equity ratio of 1% versus 52% for Haleon plc — giving it more financial flexibility in a downturn.
05Which is growing faster — PRGO or HLN?
By revenue growth (latest reported year), Perrigo Company plc (PRGO) is pulling ahead at -2.
8% versus -4. 0% for Haleon plc (HLN). On earnings-per-share growth, the picture is similar: Haleon plc grew EPS 12. 5% year-over-year, compared to -723. 2% for Perrigo Company plc. Over a 3-year CAGR, HLN leads at -0. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PRGO or HLN?
Haleon plc (HLN) is the more profitable company, earning 15.
1% net margin versus -33. 5% for Perrigo Company plc — meaning it keeps 15. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HLN leads at 22. 4% versus -26. 4% for PRGO. At the gross margin level — before operating expenses — HLN leads at 64. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PRGO or HLN more undervalued right now?
On forward earnings alone, Perrigo Company plc (PRGO) trades at 5.
5x forward P/E versus 21. 9x for Haleon plc — 16. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PRGO: 71. 8% to $20. 00.
08Which pays a better dividend — PRGO or HLN?
All stocks in this comparison pay dividends.
Perrigo Company plc (PRGO) offers the highest yield at 9. 9%, versus 2. 0% for Haleon plc (HLN).
09Is PRGO or HLN better for a retirement portfolio?
For long-horizon retirement investors, Haleon plc (HLN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
06), 2. 0% yield). Both have compounded well over 10 years (HLN: +29. 8%, PRGO: -78. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PRGO and HLN?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: PRGO is a small-cap income-oriented stock; HLN is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.